BRIBF
Price
$0.26
Change
-$0.01 (-3.70%)
Updated
May 5 closing price
Capitalization
165.94M
GNTA
Price
$4.00
Change
-$0.30 (-6.98%)
Updated
Jun 6 closing price
Capitalization
73.19M
Interact to see
Advertisement

BRIBF vs GNTA

Header iconBRIBF vs GNTA Comparison
Open Charts BRIBF vs GNTABanner chart's image
BRII BIOSCIENCE
Price$0.26
Change-$0.01 (-3.70%)
Volume$12.42K
Capitalization165.94M
Genenta Science SpA
Price$4.00
Change-$0.30 (-6.98%)
Volume$2.71K
Capitalization73.19M
BRIBF vs GNTA Comparison Chart
Loading...
View a ticker or compare two or three
VS
BRIBF vs. GNTA commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRIBF is a Buy and GNTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (BRIBF: $0.26 vs. GNTA: $4.00)
Brand notoriety: BRIBF and GNTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRIBF: 92% vs. GNTA: 46%
Market capitalization -- BRIBF: $165.94M vs. GNTA: $73.19M
BRIBF [@Biotechnology] is valued at $165.94M. GNTA’s [@Biotechnology] market capitalization is $73.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRIBF’s FA Score shows that 0 FA rating(s) are green whileGNTA’s FA Score has 0 green FA rating(s).

  • BRIBF’s FA Score: 0 green, 5 red.
  • GNTA’s FA Score: 0 green, 5 red.
According to our system of comparison, GNTA is a better buy in the long-term than BRIBF.

Price Growth

BRIBF (@Biotechnology) experienced а 0.00% price change this week, while GNTA (@Biotechnology) price change was -11.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

GNTA is expected to report earnings on Mar 28, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
BRIBF($166M) has a higher market cap than GNTA($73.2M). BRIBF YTD gains are higher at: 107.254 vs. GNTA (-8.002).
BRIBFGNTABRIBF / GNTA
Capitalization166M73.2M227%
EBITDAN/AN/A-
Gain YTD107.254-8.002-1,340%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRVI7.060.32
+4.75%
Trevi Therapeutics
BPRN30.780.49
+1.62%
Princeton Bancorp
PHG23.460.13
+0.56%
Koninklijke Philips NV
SPT21.72-0.14
-0.64%
Sprout Social
IHT2.24-0.07
-2.82%
InnSuites Hospitality Trust

BRIBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRIBF has been loosely correlated with HLVX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BRIBF jumps, then HLVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRIBF
1D Price
Change %
BRIBF100%
N/A
HLVX - BRIBF
55%
Loosely correlated
+1.53%
NRSN - BRIBF
6%
Poorly correlated
+4.07%
VIGL - BRIBF
6%
Poorly correlated
N/A
IMMX - BRIBF
6%
Poorly correlated
+8.22%
GNTA - BRIBF
5%
Poorly correlated
-6.93%
More

GNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNTA has been loosely correlated with ROQAF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GNTA jumps, then ROQAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNTA
1D Price
Change %
GNTA100%
-6.93%
ROQAF - GNTA
37%
Loosely correlated
N/A
TNFA - GNTA
28%
Poorly correlated
+5.26%
BCYC - GNTA
26%
Poorly correlated
+0.59%
PHIO - GNTA
25%
Poorly correlated
+20.33%
SRRK - GNTA
24%
Poorly correlated
-0.06%
More